STE · 10-Q · 2026Q2 · Full report

Segment Revenue Performance

STERIS plc · 2026-08-07 · Importance 55 · Surprise 32 · Matches filing data

Healthcare revenue increased 7.6% to $1,048.3 million, with service, consumable, and capital equipment revenue growth of 9.6%, 9.2%, and 1.4%, respectively. Constant-currency organic Healthcare growth was 6.4%, driven primarily by mid-single-digit volume growth and low-single-digit pricing. Healthcare backlog increased to $444.0 million from $403.5 million, primarily due to order and shipment timing and an acquisition. AST revenue grew 5.8% to $297.6 million as pricing growth was partially offset by declining volume, while Life Sciences revenue grew 8.6% to $146.7 million on mid-single-digit volume growth and low-single-digit pricing; Life Sciences backlog declined slightly to $109.9 million from $111.0 million.

Key facts

• Healthcare segment revenues for the three months ended June 30, 2026: $1,048.3 million, compared to $974.7 million for the three months ended June 30, 2025 (7.6% increase). source
• Healthcare segment backlog at June 30, 2026: $444.0 million, compared to $403.5 million at June 30, 2025. source
• Life Sciences segment revenues for the three months ended June 30, 2026: $146.7 million, compared to $135.2 million for the three months ended June 30, 2025 (8.6% increase); capital equipment +17.4%, consumable +8.2%, service +2.4%. source
• AST segment revenues for the three months ended June 30, 2026: $297.6 million, compared to $281.2 million for the three months ended June 30, 2025 (5.8% increase); constant currency organic growth 4.7%. source
• Life Sciences backlog at June 30, 2026: $109.9 million, compared to $111.0 million at June 30, 2025 (decrease). source
• Healthcare segment growth rates by type for the three months ended June 30, 2026: service +9.6%, consumable +9.2%, capital equipment +1.4%. source

Impact estimates